This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Merck Sharp & Dohme LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Tsuyoshi Oshima: Innovator in Small Molecule Inhibitors
Introduction
Tsuyoshi Oshima is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of small molecule inhibitors targeting KRAS proteins. His work is crucial in advancing therapeutic options for various diseases.
Latest Patents
Oshima holds a patent for "Small Molecule Inhibitors of KRAS Proteins." This innovation represents a step forward in cancer research, as KRAS mutations are commonly associated with several types of cancer. The patent showcases his expertise and commitment to finding effective treatments.
Career Highlights
Tsuyoshi Oshima is currently employed at Merck Sharp & Dohme LLC, a leading global healthcare company. His role at Merck allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Oshima has worked alongside talented colleagues such as Shuhei Kawamura and Yu Kobayakawa. Their combined efforts enhance the research environment and foster innovation within their projects.
Conclusion
Tsuyoshi Oshima's work in developing small molecule inhibitors is a testament to his dedication to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his collaborations further strengthen the impact of his research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile